Options Trading News

October 9, 2012  Tue 1:47 AM CT

Celsion is just below its all-time high, but one trader is looking for the pharmaceutical stock to fall back sharply.

optionMONSTER's Depth Charge system detected the purchase of 3,000 February 3 puts for $0.90. There was no open interest in the strike at the start of the session, so this is fresh buying.

CLSN fell 0.82 percent yesterday to close at $5.89, not far from its all-time high of $6.03 reached on Sept. 25. Shares of the oncology-drug developer have tripled in value since May on hopes for its ThermoDox therapy, a non-invasive cancer treatment that uses heat to target specific areas of the body.

Yesterday's put buyer appears to be positioning for the stock to revisit levels where it traded before running higher in the second half of this year. (See our Education section)
Share this article with your friends


Premium Services

Archived Webinar

Education & Strategy

The covered call and unhedged risk

I have written a few things on the Covered Call Strategy over the last two weeks. Please understand that those two previous articles plus this one do not constitute a proper, fully in-depth lesson on the Covered Call Strategy like we have in our classes at Option Monster Education. I have picked out a few topics that I believe were worth noting and today I am going to add the final one.

View more education articles »